Latest News and Press Releases

The board of directors of Photocure ASA has resolved a share capital increase pursuant to employees exercising vested options granted under the company's employee incentive scheme. The company's...

Oslo, Norway, 6 May 2015: Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused on photodynamic technologies, announces its results for first quarter 2015. Highlights include:...

Oslo, Norway, 30 April, 2015. The Annual General Meeting in Photocure ASA took place on 30 April, 2015. A new Board of Directors was elected and consists of the following members until next Annual...

Oslo, Norway, 29 April 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, refers to the first quarter 2015 report...

Photocure will present its first quarter report on Wednesday 6 May 2015 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be...

Kjetil Hestdal, President and Chief Executive Officer will present a Photocure company overview at the 2015 Nordic Life Sciences Conference hosted by the Trout Group and Pareto Securities in New...

Reference is made to the annual general meeting in Photocure ASA to be held on 30 April 2015, including the nomination committee's proposal for election of board members attached to the notice as...

Photocure's Annual Report 2014 is now available at https://www.photocure.com/Investor-relations/Reports-and-presentations/ and is also attached this notice. This information is subject to the...

Please find enclosed an invitation to the annual general meeting at Photocure ASA on 30 April 2015 at 17:00 hours (CET). The meeting will take place at Photocure's head office at Hoffsveien 4, 2nd...

  This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. ...